Global Forecasting & Insights Leader

AstraZeneca; Barcelona; Hybrid; EUR 150,000 - 210,000; Full time

Job summary

AstraZeneca is seeking a Director, Global Early Asset & Business Development to lead early forecasting and investment case support across pre-clinical to Phase 3 readiness. You will partner with Finance, Market Access, Medical, and Business Development to translate signals into strategy and action, shaping a high-impact R&I portfolio.

The role requires strong scientific and business acumen, 6+ years in forecasting or early-stage pipeline strategy, and a track record of influencing senior

Qualifications

• Bachelor’s degree required; advanced degree preferred (MBA, MS, or PhD in a relevant quantitative, scientific, or life‑sciences discipline)
• 6+ years of relevant experience in pharma, biotech, or consulting, focused on forecasting, early‑stage pipeline strategy, or commercial market insights; experience supporting business development a plus
• Strong scientific and business acumen
• Scientific agility to delve into new indications, modalities, and biological targets
• Comfort with NPV, risk‑adjusted forecasting, scenarios, and sensitivity testing for investment cases
• Strong understanding of key commercial drivers, market access dynamics, pricing, reimbursement, and policy factors, particularly in the US and major global markets
• Clear, concise communicator who turns complex data into actionable recommendations for senior stakeholders and governance
• Demonstrated ability to build trust and alignment across global and US stakeholders

Responsibilities

• Lead early forecasting and scenario planning across epidemiology, market adoption, and policy shifts
• Develop patient-based forecast models and benchmark external analogs to inform investment cases
• Support investment decisions for in-licensing, partnerships, and acquisitions with clear recommendations
• Prepare governance narratives and executive updates for portfolio prioritization and decision reviews
• Advise senior leaders on forecast drivers, model changes, and implications for pipeline strategy
• Contribute to Disease Strategy Team with insights on unmet need and market evolution
• Oversee vendor-led market research to inform investment decisions and strategy
• Identify AI/automation opportunities to improve speed and explainability of insights

Skills

Scientific acumen

Business acumen

Strong communication

Leadership

Forecasting

Stakeholder management

Education

MBA / MS / PhD in quantitative or life-sciences

Bachelor's degree required

Job description

AstraZeneca is seeking a Director, Global Early Asset & Business Development to lead early forecasting and investment case support across pre-clinical to Phase 3 readiness. You will partner with Finance, Market Access, Medical, and Business Development to translate signals into strategy and action, shaping a high-impact R&I portfolio.

The role requires strong scientific and business acumen, 6+ years in forecasting or early-stage pipeline strategy, and a track record of influencing senior